Report Highlights
The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.
Report Includes
- An overview of the global markets for eldercare products and services.
- Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
- Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.
- Breakdowns of the U.S. and worldwide markets by demographics.
- A focus on applications including:
- Heart disease/stroke.
- Cancer treatments.
- Kidney disease medications.
- Diabetes medications.
- Arthritis prescription medications.
- Osteoporosis medications.
- Pain medications.
- Neurological health medications (e.g., dementia, depression).
- Respiratory medications and products.
- Information covering the industry's structure.
- Profiles of major players in the industry.
SCOPE OF REPORT
This report offers forecasts by product segment (i.e., healthcare, housing, and assistive devices and technology) from 2015 through 2020, including supporting analyses for projections.
Report segments include a demographic background of the market in the U.S. and worldwide, healthcare products and services, housing services and needs, and assistive technologies for the elder care market. International markets are discussed and information is provided on industry structure.
Profiles of leading companies involved in the elder care pharmaceutical, housing and assistive device industries are provided. Information on company placement within the designated market and strategic analyses of the companies’ available and emerging products are discussed.
ANALYST'S CREDENTIALS
Peggy S. Lehr is the market research analyst of this report. Ms. Lehr holds a BS in Journalism from the University of Colorado, Boulder, and a MS in Communication from the University of Denver. Ms. Lehr has been involved with the medical/nursing industry for more than 25 years.
Report Highlights
The U.S. eldercare market reached $286.7 billion in 2012. This market is expected to grow from $319.8 billion in 2013 to $436.6 billion by 2018, with a compound annual growth rate (CAGR) of 6.4% for the five-year period, 2013 to 2018.
Report Includes
- An in-depth analysis and forecast of the eldercare market.
- Analyses of market trends, with data from 2012, estimates for 2013, and projections of CAGRs for the period 2013 and 2018.
- Identification of the U.S. and worldwide markets by demographics.
- Discussion on international markets, as well as information on the industry's structure.
- A breakdown of the overall market into segments that include healthcare products and services, housing services and needs, and assistive technologies.
Report Highlights
- The U.S. eldercare market was worth $279.2 billion in 2008 and an estimated $316.9 billion in 2009. This should reach $447.4 billion in 2014, for a compound annual growth rate (CAGR) of 7.1%.
- The healthcare segment has the largest share of the market, worth $146.4 billion in 2008 and an estimated $172.2 billion in 2009. This should increase at a CAGR of 9.1% to reach $266.8 billion in 2014.
- The housing segment has the second-largest market share, generating $127.4 billion in 2008. This segment is expected to reach $138.7 billion in 2009 and $171.5 billion in 2014, for a CAGR of 4.3%.
Related Reports
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Medical Robotics and Computer-assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Pain Management Drugs and Devices
The global market for pain management drugs and devices is expected to increase from $84.6 billion in 2023 to $109.9 billion by the end of 2028, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2023-2028.
The Market for Minimally Invasive Medical Devices
The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.
Recent Reports
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets
The global market for radiation therapy products and radiopharmaceuticals is expected to grow from $17.5 billion in 2024 and is projected to reach $31.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 12.3% during the forecast period of 2024 to 2029.
Routine Health Screening Market
The global market for routine health screening is expected to grow from $59.7 billion in 2024 and is projected to reach $82.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
Elder Care Services and Assistive Devices: Global Markets
The global market for elder care services and assistive devices is expected to grow from $868.2 billion in 2024 and is projected to reach $1.1 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2024 to 2029.
Direct-to-Consumer Testing Industry: Global Markets
The global market for direct-to-consumer (DTC) testing is estimated to increase from $1.6 billion in 2023 to reach $3.2 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.
Health and Medical Insurance Providers: Global Markets
The global market for health and medical insurance providers is expected to grow from $2.2 trillion in 2023 to $3.4 trillion by the end of 2028, at a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2023 to 2028.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More